Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Altan

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Clinical Radiology|June 9, 2021
Post-immunotherapy imaging in lung cancerG S Shroff, C D Strange, M Altan, et al.
Oral Oncology|March 9, 2024
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective studyL Guimaraes de Sousa, S Liu, P Bhosale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2019
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expressionE J Aguilar, B Ricciuti, J F Gainor, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2023
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung CancerM Altan, F Soto, T Xu, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Clinical Radiology|June 9, 2021
Post-immunotherapy imaging in lung cancerG S Shroff, C D Strange, M Altan, et al.
Oral Oncology|March 9, 2024
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective studyL Guimaraes de Sousa, S Liu, P Bhosale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2019
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expressionE J Aguilar, B Ricciuti, J F Gainor, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2023
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung CancerM Altan, F Soto, T Xu, et al.
Pageof 6